COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
17/09/2025
The European Journal of Pediatrics publishes the first-ever multicenter clinical trial results demonstrating that the Vivos DNA appliance — part of the company’s C.A.R.E. line of devices— is both safe and effective for [...]
Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision
17/09/2025
Company Appoints New Directors with Deep Expertise in Venture Capital, Financial Due Diligence, and Bitcoin Mining to Guide Next Phase of Growth SCOTTSDALE, AZ, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. ( [...]
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
17/09/2025
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly [...]
Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research
17/09/2025
Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials CAMBRIDGE, Mass., [...]
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
17/09/2025
Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company [...]
Digital Utilities Ventures Provides Corporate Update
17/09/2025
International contracts, pending FINRA approvals, and OTCQB uplisting efforts position DUTV for expanded revenues and improved market visibility MANKATO, Minn., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Digital Utilities [...]
PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference
17/09/2025
PETACH TIKVA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that management will [...]
Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment
17/09/2025
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company [...]
Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
17/09/2025
BOSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed [...]
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
17/09/2025
Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP MELBOURNE, Australia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by the UK’s Medicine [...]
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair
17/09/2025
– Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of their innovations – SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ADARx [...]
Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
17/09/2025
PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promising signals regarding the efficacy of PALI-2108 in [...]
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
17/09/2025
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a [...]
Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
17/09/2025
DALLAS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ® , the world’s first digitally printed single-point midline oral appliance [...]
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
17/09/2025
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) , a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev , one of the [...]
24/7 Market News: Kraig Labs Spider Silk is Sustainable Alternative to Petroleum-Derived Plastics
17/09/2025
Nylon and Polyester Are Polluting the Planet with Microplastics DENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and [...]
New Study Highlights the Potential of Hyperbaric Oxygen Therapy as a Biologically Based Treatment for Long-Term PTSD Symptom Improvement
17/09/2025
The study examined the long-term relief of PTSD symptoms in male veterans, highlighting the significant impact HBOT can have on alleviating the debilitating daily challenges they face ORLANDO, Fla., Sept. 17, 2025 ( [...]
Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD
17/09/2025
Complete 26-week results further demonstrate that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of semaglutide-induced loss of lean mass, while increasing fat mass loss [...]

Pages